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Origin of metastable oligomers and their effects on
amyloid fibril self-assembly†
Filip Hasecke,‡a Tatiana Miti,‡b Carlos Perez,b Jeremy Barton,b Daniel Scho¨lzel,ac
Lothar Gremer, ac Clara S. R. Gru¨ning,a Garrett Matthews,b Georg Meisl, d
Tuomas P. J. Knowles, d Dieter Willbold, ac Philipp Neudecker, ac
Henrike Heise, ac Ghanim Ullah,b Wolfgang Hoyer *ac and Martin Muschol *b
Assembly of rigid amyloid fibrils with their characteristic cross-b sheet structure is a molecular signature of
numerous neurodegenerative and non-neuropathic disorders. Frequently large populations of small
globular amyloid oligomers (gOs) and curvilinear fibrils (CFs) precede the formation of late-stage rigid
fibrils (RFs), and have been implicated in amyloid toxicity. Yet our understanding of the origin of these
metastable oligomers, their role as on-pathway precursors or off-pathway competitors, and their effects
on the self-assembly of amyloid fibrils remains incomplete. Using two unrelated amyloid proteins,
amyloid-b and lysozyme, we find that gO/CF formation, analogous to micelle formation by surfactants, is
delineated by a “critical oligomer concentration” (COC). Below this COC, fibril assembly replicates the
sigmoidal kinetics of nucleated polymerization. Upon crossing the COC, assembly kinetics becomes
biphasic with gO/CF formation responsible for the lag-free initial phase, followed by a second upswing
dominated by RF nucleation and growth. RF lag periods below the COC, as expected, decrease as
a power law in monomer concentration. Surprisingly, the build-up of gO/CFs above the COC causes
a progressive increase in RF lag periods. Our results suggest that metastable gO/CFs are off-pathway
from RF formation, confined by a condition-dependent COC that is distinct from RF solubility, underlie
a transition from sigmoidal to biphasic assembly kinetics and, most importantly, not only compete with
RFs for the shared monomeric growth substrate but actively inhibit their nucleation and growth.
Introduction
Deposits of protein aggregates forming non-branching rigid
brils (RFs) with a characteristic cross-b sheet architecture are
closely associated with a wide range of human disorders
including Alzheimer's and Parkinson's disease, as well as non-
neuropathic amyloidoses such as type-II diabetes and heredi-
tary lysozyme amyloidosis.1–9 More recently, amyloid formation
has also been associated with functional biological responses.10
Beyond late-stage RFs, amyloid formation frequently involves
morphologically distinct, long-lived and highly populated
metastable intermediates. Globular amyloid oligomers (gOs)
and their associated highly curvilinear brils (CFs), oen
referred to as protobrils, have been observed with large
numbers of amyloid proteins and over a wide range of growth
conditions.11–21 Substantial evidence suggests that early-stage
gOs are potent sources of cytotoxicity in amyloid
diseases.19,22–30 Metastable oligomers also affect the aggregation
of pharmaceuticals,31 and might hold answers to the question
what distinguishes functional from pathological amyloid
species.3,10 Formation of metastable precursors relates to
a variety of physiochemical and biomedical problems.32 This
includes metastable liquid phases as precursor of protein
crystallization33 or sickle-cell hemoglobin brillation,34 as well
as the signicance of membrane-less organelles in promoting
ALS bril formation.35 Some amyloid oligomers themselves
have been suggested to share characteristics of disordered
liquid-like states.36,37
Characterizing the mechanisms and developing solutions to
kinetic schemes that replicate RF nucleation and growth
kinetics in the absence of long-lived, metastable intermediates
has made signicant progress.38,39 These models helped identify
secondary nucleation mechanisms as critical contributors to
the process of bril nucleation. Analysis of the scaling behavior
of reaction half-times vs.monomer concentrations now permits
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quantication of the relative contributions of distinct growth
mechanisms to bril formation.39–41 In contrast, the conditions
required for the formation of signicant concentrations of long-
lived, metastable amyloid oligomers, which are distinct from
the inherently minor populations of small, on-pathway bril
seeds, remain uncertain. Similarly, the mechanisms by which
these metastable oligomers are replaced by late-stage RFs
continue to be elusive. The role metastable states play in the
nucleation and growth of late-stage RFs has important impli-
cations for our understanding of amyloid pathogenesis and
informs efforts at intervening with their formation. Yet, it
remains unresolved whether metastable globular oligomers are
obligatory or optional precursors of bril growth, and whether
they serve as on-pathway precursors or represent off-pathway
competitors of late-stage RFs.13 Two prevalent models for the
role of globular oligomers are nucleated conformational
conversion (NCC) vs. nucleated polymerization with competing
off-pathway oligomers (cNP) (Fig. 1A). In NCC, oligomers are on-
pathway but structurally distinct precursors of RFs; restructur-
ing of oligomers into RF seeds represents the rate-limiting
nucleation step.42,43 In cNP, RFs nucleate via “classical nucle-
ation” from the monomer pool while metastable oligomers and
curvilinear brils are off-pathway competitors to RF nucleation
and growth.44,45 It is difficult to distinguish these scenarios since
both predict qualitatively identical temporal sequences of
aggregate populations and growth kinetics.
We have previously reported the separation of the parameter
space for amyloid assembly of lysozyme in dependence of
protein and salt concentration (Fig. 1B).46,50 One regime is
typied by nucleated polymerization of rigid amyloid brils
without discernible populations of metastable intermediates.
The other regime results in lag-free formation of readily
detectable globular oligomer (gOs) which tend to assemble into
highly curvilinear brils (CFs), i.e. brils with distinctly shorter
persistence lengths than their rigid bril (RF) counterparts. A
colloidal model accounting for the free-energy cost of charge
Fig. 1 Amyloid oligomer model systems. (A) Schematic of potential roles for globular oligomers (gOs) and their curvilinear fibrils (CFs) in late-
stage rigid fibril (RF) formation. (Top) Globular oligomers (gOs) and their curvilinear fibrils (CFs) are presumed to assemble prior to late-stage
formation of RFs. The dashed lines represent the potential nucleation pathways for RFs either via nucleated conformational conversion (NCC)
from gO/CFs or via nucleated polymerization from monomers, with RFs competing with off-pathway gO/CF formation (cNP). (Bottom)
Nucleated polymerization (NP) of RFs from monomers only, i.e. in the absence of metastable gO/CFs. The transition for fibril formation in the
absence or presence of gO/CF occurs upon crossing some monomer threshold called the “critical oligomer concentration” (COC, blue dotted
line) (B) phase diagram for lysozyme at pH 2, 52 C (adapted from ref. 46). Open orange circles indicate protein/salt concentrations resulting in
RFs without gO/CF formation, as assessed by thioflavin T (ThT) and light scattering kinetics as well as time-resolved atomic force microscopy
(AFM). Blue circles specify conditions for lag-free onset of gO/CF growth. The blue curve represents the fit from a colloidal model to the protein-
and salt-dependent COC. The dashed vertical line indicates the transition from RF growth without build-up of metastable oligomeric species
(below COC) to oligomeric RF growth (above COC) upon increasing monomer concentration, as applied in this study. (C) Morphologies of
lysozyme (top) and dimAb (bottom) gOs and CFs formed above their respective COCs, imaged using AFM. Color scale: height in nm. (D) Top:
Amide I band infrared spectra of hewL monomers vs. gO/CFs or RFs, both after separation frommonomers. Bottom: gO/CF and RF spectra after
subtraction of monomer reference (adapted from ref. 54) (E) scheme of the dimeric Ab40 construct dimAb. Two Ab40 units are linked in a single
chain in a head-to-tail fashion. An N-terminal methionine affords recombinant expression. A flexible (G4S)4 linker was chosen to provide the
Ab40 units with conformational freedom. (F) Far-UV CD spectra of dimAb before and after gO/CF formation, recorded at 4 C or 20 C,
respectively, at a protein concentration of 20 mM.
5938 | Chem. Sci., 2018, 9, 5937–5948 This journal is © The Royal Society of Chemistry 2018
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repulsion among monomers upon connement to an oligomer
replicated the prominent protein- and salt-dependence of the
sudden onset of gO formation in hen egg-white lysozyme (hewL)
(Fig. 1B).46 Due to these strong similarities with the onset of
micelle formation in charged surfactant system we labelled this
transition the “critical oligomer concentration” or COC.47 Our
observations also resembled a transition of b2-microglobulin
amyloid assembly upon changes in solution pH.48,49 The gOs
formed by hewL above the COC displayed the basic character-
istics of small oligomers observed with multiple amyloid
proteins, including those of b2-microglobulin, transthyretin,
Ab40/42, and a-synuclein.14,20,21,51–53 These characteristics
include the globular morphology, the size of a few nanometers
(Fig. 2E-I), the propensity to assemble into curvilinear brils
(Fig. 1C, top, and Fig. 2E-II), and the muted ThT responses they
elicit.54 Their IR spectra showed prominent peaks in the char-
acteristic “amyloid band”, which were slightly but consistently
shied with respect to those of their RF counterparts (Fig. 1D).55
An additional weak peak near 1690 cm1 hints at a potential
antiparallel b-barrel architecture, now reported for multiple
amyloid oligomers.56 The tinctorial and spectroscopic features
of hewL gOs therefore replicate the limited number of high-
resolution structures of early-stage amyloid gOs in other
systems.57,58 We also conrmed that gO/CFs were metastable as
RFs seeded above the COC readily grew while gO/CFs seeded
below the COC slowly decayed. In short, metastable gO/CFs of
hewL are conned by their COC to a subset of conditions
permissive of bril growth and are therefore nonobligatory
intermediates of bril growth (Fig. 1B).
These results raised a series of questions we set out to
answer. First, is formation of metastable gO/CFs typically
conned above a threshold protein concentration, i.e. a COC?
Does it depend whether a folded or an intrinsically disordered
protein undergoes amyloid assembly? Are these metastable gO/
CFs on-pathway precursors or off-pathway byproducts of
amyloid assembly? Most importantly, does the emergence of
metastable gO/CFs above the COC alter RF nucleation and
growth, and if so, in what ways? We chose to address these
questions by comparing a single-chain Ab dimer (dimAb)
against the behaviour of hen egg-white lysozyme (hewL). While
Ab is a disordered monomer and the key component of protein
deposits associated with Alzheimer's disease, hewL is a folded
protein closely related to hereditary lysozyme amyloidosis. The
dimeric Ab construct increases the local concentration of Ab
monomers and, thereby, lowers the threshold for oligomer
formation in vitro. As detailed below, it also promotes the
separation of timescales for gO/CF vs. RF formation and,
thereby, permits separate analysis of their intrinsic kinetics. We
show that, for both dimAb and hewL, RF assembly kinetics
changes from purely sigmoidal to biphasic upon crossing
a protein- and condition-specic COC. The initial phase in
biphasic kinetics represents the lag-free formation of gO/CFs
while the second phase indicates RF nucleation and growth.
Analysing the RF component, we nd that the increasing levels
of gO/CFs above the COC progressively slow RF formation, as
evident in increasing RF lag periods. As we argue below, the
formation of metastable gO/CFs therefore alters RF nucleation
and growth in ways that neither of the currently dominant
models of NCC and cNP fully captures.
Results
Single-chain Ab dimer as amyloid oligomer model system
Formation of metastable gO/CFs of Ab has been linked to
neurotoxicity in Alzheimer's disease.11,12,22,24,26,28–30,59 To facilitate
determination of the effects of gO/CFs on Ab bril formation,
we introduce here a single-chain dimeric variant of Ab40 termed
dimAb. In dimAb, two Ab40 units are connected through
a exible glycine–serine-rich linker in a head-to-tail fashion
(Fig. 1E). A relatively long (20 amino acids), exible linker was
chosen to guarantee minimal disturbance of the conforma-
tional properties of Ab in monomeric as well as aggregated
states. This is especially important in the light of previous work
on Ab dimer constructs that suggested that short linkages via
disulde bridges restrict the accessibility of the RF state.30,60–62
In the case of dimAb, solution NMR of the monomeric construct
retrieves the resonances of monomeric Ab40, indicating that the
two Ab subunits in dimAb do not affect each other's largely
disordered conformation (Fig. S1†). According to AFM
(Fig. S2A†) and solid-state NMR spectroscopy (Fig. S2B and C†)
the end product of dimAb assembly, as for Ab40, are RFs. A 2D
INEPTMAS spectrum, which only displays mobile regions of the
brils, almost exclusively picks up signals from glycine and
serine residues. This indicates that the linker in dimAb RFs
remains exible, while both Ab subunits are incorporated into
the RF b-sheet core (Fig. S2B†). Ab40 and Ab42 were previously
shown to exhibit biphasic assembly kinetics at elevated protein
concentrations.63–66 The linkage of two Ab units was chosen to
increase the local Ab concentration, thereby promoting the
highly concentration-dependent gO/CF formation. Compared
to Ab40 and Ab42, this provides the separation of the two
kinetics phases, i.e. the time regimes with dominant gO/CF or
RF formation, at much reduced total incubation times and
protein concentrations, important for the subsequent analysis
of gO/CF and RF kinetics (see below). As seen by AFM and CD
spectroscopy, dimAb does readily form gO/CFs with morphol-
ogies (Fig. 1C) and b-structure (Fig. 1F) similar to those
observed with hewL.
Formation of gO/CFs induces switch from sigmoidal to
biphasic assembly kinetics
The time courses of amyloid bril assembly for both hewL and
dimAb undergo a discontinuous transition from purely
sigmoidal to biphasic kinetics, as monitored by the amyloid
indicator dye ThT (Fig. 2A and C). Below the transition (orange
traces), ThT shows no discernible increase during an extended
lag period lasting many hours to days. The atness of the initial
plateaus is highlighted in Fig. 2A and D by using a logarithmic
axis for the ThT signal. This initial plateau is followed by
a dramatic upswing in ThT emission which eventually satu-
rates. Upon crossing a monomer concentration of about 1.5 mM
dimAb or 40 mM hewL, at their respective solution conditions,
the kinetics changes discontinuously (blue traces, Fig. 2A and
This journal is © The Royal Society of Chemistry 2018 Chem. Sci., 2018, 9, 5937–5948 | 5939
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C). Slightly above the transition, ThT responses display a small
but steady upward dri from the outset, followed by a prom-
inent upswing at a time point consistent with RF nucleation and
growth. By further raising monomer concentration the biphasic
character of the kinetics becomes increasingly prominent, with
the initial phase reaching a saturation plateau well before the
second upswing in ThT response. The hewL traces shown in
Fig. 2C emphasize another features of biphasic kinetics. The
second upswing above the COC, while present, becomes less
pronounced and the ThT amplitude at 96 hours decreases even
though monomer concentration increases. As shown below, the
progressive decrease in ThT response at this time point corre-
lates with the increasing concentrations of residual gO/CFs.
Both of these features support the model of RF assembly in
the presence of gO/CFs put forth below. The ThT trace for hewL
in Fig. 2E emphasize the biphasic character of hewL kinetics.
The biphasic kinetics reported here extend our prior observation
that the onset of a lag-free increase in ThT and light scattering
kinetics in hewL coincided with the onset of gO/CF formation.
Using AFM imaging, we conrmed that the sigmoidal
kinetics indicated RF growth without detectable intermediates
while biphasic kinetics represented the sequential growth of
gO/CFs during the initial phase and RF nucleation and growth
during the secondary phase. AFM images of aliquots sampled
for hewL growth below the COC indeed only detect monomers
within the lag phase and accumulating numbers of brils of
increasing length during the rise and subsequent plateau in
ThT (Fig. 2D). The extended lag periods with no discernible
bril nucleation/growth matches well with the predictions from
nucleated polymerization dominated by autocatalytic secondary
nucleation mechanisms (see ts below). In contrast, AFM
images of aggregate populations sampled during the initial
phase of biphasic growth only show signicant buildup of small
gOs and CFs. This matches with the high reaction-order of gO/
CF formation discussed below. Following the second upswing,
in turn, AFM detects RFs in the solution (Fig. 2B and E). While
AFM images of samples taken near the end of the kinetics traces
clearly show RFs, signicant populations of residual gO/CFs
Fig. 2 Transition from sigmoidal to biphasic growth kinetics upon oligomer formation. Transition from sigmoidal (orange) to bimodal (blue)
amyloid growth kinetics of dimAb (A, B) and hewL (C–E), as monitored by ThT fluorescence. Concentration dependent time traces of (A, B) dimAb
assembly in 50 mM Na-phosphate, 50 mM NaCl, pH 7.4, 37 C, and (C–E) hewL assembly in 25 mM K-phosphate, pH 2.0, 52 C, with 450 (C, E)
and 500 (D) mMNaCl, respectively. Typical sigmoidal (D) and bimodal (B, E) growth kinetics correlated to AFM images of aggregatemorphologies
at the indicated time points (I–V) and concentrations of 20 mM dimAb (B), 21 mM hewL (D), and 280 mM hewL (E), respectively.
5940 | Chem. Sci., 2018, 9, 5937–5948 This journal is © The Royal Society of Chemistry 2018
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persist and their concentrations increase with monomer
concentration above the COC. For hewL, for example, an addi-
tional two weeks of incubation were required before RFs had
completely replaced gO/CFs. Hence, the apparent decline in the
ThT amplitude above the COC (Fig. 2C) arises from the
increasing populations of (weakly ThT positive) residual gO/CFs
and their glacial pace of depolymerisation into (strongly ThT
positive) RFs.
Inherent metastability of gO/CFs
The slow depletion of gO/CFs by RFs highlights perhaps the
most distinctive feature of gO/CFs: their intrinsic metastability
against RF formation.13,46 We previously corroborated the
metastability of hewL gO/CFs by seeding solutions above the
COC with RFs, which readily grew and replaced gO/CFs. Simi-
larly, isolated gO/CFs, when seeded into monomeric solutions
below the COC, dissolved and did so at progressively faster rates
the further monomer concentrations were below the COC.46
Fig. 3A exemplies this behavior by showing the kinetics of an
unseeded, RF seeded and gO/CF seeded monomer solution,
with the total monomer concentration aer seeding remaining
below the COC. While seeding with isolated RFs induced lag-
free RF elongation, seeding with isolated gO/CFs at identical
concentrations caused their slow decay and increased the RF lag
period compared to the unseeded sample. Moreover, we previ-
ously established that the binding protein ZAb3, which
sequesters monomeric Ab, achieves dissolution of Ab42 gO/CFs
but not of Ab42 RFs.65,67 Here, we used ZAb3 as a tool to monitor
the slow depletion of gO/CFs and the concomitant RF growth
(Fig. 3B). When an excess of ZAb3 is added to dimAb assembly
reactions before the second ThT upswing, uorescence
vanishes almost completely on the time scale of hours, indi-
cating dissolution of gO/CFs at the expense of formation of the
dimAb:ZAb3 complex. In contrast, when ZAb3 is added aer the
second ThT upswing, the amplitude of the uorescence drop
progressively decreases the later ZAb3 is added, reecting the
increasing formation of stable RFs and concomitant decrease of
gO/CFs susceptible to disaggregation into the dimAb:ZAb3
complex (Fig. 3B). Incubation of preformed dimAb:ZAb3
complexes in the presence of sonicated dimAb RF seeds resul-
ted in the dissociation of the dimAb:ZAb3 complex at the
expense of RF growth (Fig. S3†). Thus the dimAb states can be
ordered according to their thermodynamic stability: RF-
incorporated > ZAb3-bound > gO/CF-incorporated (Fig. 3C).
This indicates substantially higher thermodynamic stability of
RFs compared to gO/CFs.
High reaction order of gO formation
As noted above, using the dimeric Ab construct helped to
separate the time regimes of dominant gO/CF vs. RF formation
sufficiently to allow separate analysis of the gO/CF assembly
kinetics (Fig. 4A and B). A global t to the concentration-
dependent time course of the initial uorescence increase
with a primary nucleation-growthmodel,68 assuming a common
nucleus size as well as common nucleation and elongation rate
constants, shows clear systematic deviations (Fig. 4A). However,
it could be t to an nth-order oligomerization reaction with
a global rate constant for all concentrations (Fig. 4B). The
reaction order obtained from global ts to three independent
data sets was 3.3  0.2, reecting the high concentration
dependence of gO/CF formation. This high reaction order
explains the observability of a well-dened COC. Considering
that one dimAb molecule contains two Ab units, the reaction
order of 3.3 suggests an oligomer size of six to seven Ab units,
which is compatible with previous studies indicating a prom-
inent role of hexamers in Ab assembly.69–72 For hewL, gO/CF and
RF kinetics overlapped, requiring a simultaneous t to both gO/
CF and RF growth (Fig. 4C), with the gO/CF portion better
Fig. 3 Metastability and RF seeding incompetence of gO/CFs. (A) HewL RF kinetics below the COC (38 mMhewL, 400mMNaCl) without seeding
(black), or after seeding with isolated gO/CFs (blue) or RFs (orange) at either 3.5 or 7 mM each, and incubated at pH 2, T¼ 52 C. (B) ThT-detected
dissociation of pre-assembled dimAb upon addition of the binding protein ZAb3 (grey), which sequesters monomeric dimAb in a b-hairpin
conformation (red, see ref. 65 and 67). The complex is shown in ribbon representation, hydrophobic side chains of ZAb3 in direct contact with the
Ab40 b-hairpin are shown as spheres (Protein Data Bank entry 2OTK). The assembly of 6 mM dimAb was monitored by ThT fluorescence, with
addition of 14 mM ZAb3 at different time points, indicated by red lines. Addition of ZAb3 during the gO/CF formation-dominated time regime
results in nearly complete loss of ThT fluorescence, while ZAb3 addition during the RF-dominated time regime leads to a progressive decrease in
the amplitude of the fluorescence drop. (C) Energy diagram illustrating the order of thermodynamic stability of different states of Ab, above the
COC and under the present experimental conditions.
This journal is © The Royal Society of Chemistry 2018 Chem. Sci., 2018, 9, 5937–5948 | 5941
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represented by rst-order kinetics. The near rst-order kinetics
of hewL gO/CFs probably reects the propensity of hewL gOs to
assemble further into CFs (see Fig. 2E), with a simultaneous
decrease in net reaction order. However, the exponential rate
constant tting the gO/CF data increased as a non-linear 3rd-
order function in monomer concentration (Fig. 4C, inset), again
suggesting a high reaction-order for the initial gO formation
step. In both cases, the concentration dependence of gO/CF
formation is much higher than the one for RF formation, for
which negative scaling exponents down to only 1.7 were re-
ported.73 These observations indicate once more that gO/CF
formation occurs through a fundamentally different reaction
mechanism than RF formation and rapidly becomes the
initially dominant growth process above the COC.
GO/CFs are retarding RF nucleation and growth
Crossing the COC results in a sharp transition from RF nucle-
ation and growth in the absence of metastable gO/CFs to their
concurrent growth. This provides the unique opportunity to
evaluate how gO/CFs alter the mechanisms of RF nucleation
and growth, while maintaining xed solution conditions and
monomer conformations. Theoretical considerations indicate
that RF lag periods follow specic scaling laws as function of
monomer concentration, with the magnitude of the scaling
coefficients providing information about the underlying
molecular mechanisms of bril nucleation and growth.39,74Here
we investigated whether and how the presence of increasing
concentrations of gO/CFs above the COC altered these scaling
laws for RF nucleation and growth. It is worth mentioning that
this comparison is valid irrespective of whether RFs nucleate via
homogeneous or heterogeneous nucleation mechanism(s). In
the absence of metastable gOs (i.e. below the COC) we t RF
kinetics with the analytical expression for nucleated polymeri-
zation with secondary mechanisms that ignores late-stage
monomer depletion (early time approximation of eqn (1), see
Materials and methods in the ESI† and ref. 38). Besides the
quality of the individual ts (Fig. 5A), the net rate for primary
and secondary nucleation extracted varied within a narrow
range (Fig. 5B). The dominance of secondary over primary
nucleation (Fig. 5B) reects the highly cooperative character of
RF nucleation, as already apparent from the initially completely
at ThT responses. The critical importance of autocatalytic
nucleation mechanisms replicates prior observations with
a multitude of amyloid proteins.38,74
To t RF kinetics of dimAb above the COC, we rst sub-
tracted the global ts of the gO/CF formation time regime to an
oligomerization reaction from the entire time traces (Fig. 5D).
The resulting time courses represent the RF portion of the ThT
signal. This treatment disregards the depletion of gO/CFs aer
the second ThT upswing. However, this introduces only
a negligible error into the determination of lag-times, as gO/CF
depletion is slow and becomes signicant only long aer the lag
phase (see AFM images for Fig. 2B and E). Lag-times were ob-
tained from the RF portions of the data by applying the same ts
as for RF kinetics below the COC. In the case of hewL the time
regimes of dominant gO/CF formation and dominant RF
formation above the COC were not as clearly separated. We
therefore tted the data simultaneously to a combination of the
above analytical approximation for RF growth (eqn (1)†) with
a saturating exponential growth for gO/CFs (eqn (4)†). Fig. 4C
indicates that the resulting ts were good when limited to the
early stages of RF nucleation. Subtraction of the gO/CF
component of the ts from the raw data again yielded the
sigmoidal time traces expected for the RF portion of the ThT
data (Fig. 5C).
Several striking features emerge from the log–log plots for RF
lag time vs. protein concentration (Fig. 5E and F). The lag
periods below the COC (orange) do decrease as a power law in
monomer concentration, with scaling exponents yielding values
of a ¼ (0.24  0.07) and a ¼ (0.32  0.05) for hewL and
dimAb, respectively. As recently shown, scaling exponents below
a magnitude of 0.5 indicate that dock and lock steps upon
monomer addition at the growing bril end become rate-
limiting of bril elongation.39 Neglecting gO/CF formation,
one would expect lag periods above the COC to continue to
shorten as indicated by the extrapolation of the power law ob-
tained below the COC (Fig. 5E and F, solid black lines). While
this holds true for some data points just above the COC, rapidly
increasing formation of gO/CFs above the COC not only arrests
Fig. 4 gO formation kinetics. (A, B) Concentration-dependent kinetics of gO/CF formation of dimAbmonitored by ThT fluorescence. Global fits
to the data were performed using (A) a primary nucleation-growth model (eqn (2); see Materials and methods in the ESI†) or (B) a one-step
oligomerization model (eqn (3)†). The reaction order obtained from the global fit to the data set in (B) was 3.4 0.1. (C) Fits to the early stages of
hewL ThT kinetics combining a single-exponential with the model for nucleated polymerization (eqn (4) & (1)†). The inset shows the power-law
increase in the exponential growth rate required to fit the data.
5942 | Chem. Sci., 2018, 9, 5937–5948 This journal is © The Royal Society of Chemistry 2018
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the decrease but progressively increases RF lag periods with
increasing protein concentration, as shown by the blue data
points. A leveling off of the lag periods would be consistent with
gO/CFs as off-pathway competitors of RFs. As monomer
concentrations exceed the COC, the increasingly rapid pace of
gO/CF formation eventually depletes monomers down to their
value at the COC. As a result RF nucleation rates from mono-
mers would be reduced to their value at the COC. The experi-
mentally observed rapid increase in RF lag periods, though,
implies that gO/CFs actively inhibit RF nucleation beyond the
capacity for off-pathway aggregates to buffer monomer
concentrations.
GO/CFs act as off-pathway competitors of RFs, not as on-
pathway precursors
The above changes in scaling behaviour of lag periods upon
onset of oligomer formation speak to the broader question
whether gO/CFs are on-pathway precursors or off-pathway
competitors of RF growth. To be effective precursors of RF
seed formation, gO/CFs should decrease the lag periods upon
crossing the COC. Even if gO/CFs are only slowly converting to
RFs, lag periods above the COC should, at best, level off.
Instead, lag periods increase. Hence, nucleated conformational
conversion (NCC) of the gO/CFs observed here into RF seeds is
not a feasible mechanism. Our qualitative observation that AFM
imaging of samples with particularly high concentrations of gO/
CF failed to generate RFs for weeks further corroborates the off-
pathway character of gO/CFs.
As additional conrmation that hewL gO/CFs are incapable of
conversion into RFs on the time scale of spontaneous RF nucle-
ation from monomers we seeded isolated gO/CFs or RFs into
solutions below the COC. As shown in Fig. 3A, controls without
addition of seeds (black traces) underwent traditional nucleated
polymerization. Seeding with preformed and isolated RFs
(orange traces) eliminated the lag period and resulted in imme-
diate bril elongation. In contrast, adding identical concentra-
tions of gO/CF seeds (blue traces) increased RF lag periods just as
observed above the COC. This further supports the conclusion
that gO/CFs, instead of being on-pathway for RF nucleation,
retard the process of RF nucleation frommonomers. The data in
Fig. 3A also address the unlikely scenario that we might have
missed small populations of gO/CFs already present below the
COC, which in turn dominate nucleation rates under those
conditions. The signicant increase in the ThT baseline upon
adding gO/CFs indicates that their concentrations are well above
any vanishingly small levels of gO/CF present below the COC. Yet,
even at those high concentrations, they do not promote RF
formation. Notably, the progressively prominent inhibitory effect
of gO/CF formation on RF nucleation and growth with increasing
protein concentration falls outside the current versions for off-
pathway oligomer formation as well.
Numerical simulations of biphasic off-pathway oligomer
growth
The above data suggest that gO/CFs are off-pathway products
that emerge only over the limited range of amyloid bril growth
Fig. 5 gO/CFs are retarding RF nucleation and growth. (A) Fit to ThT kinetics of hewL RFs below the COC with the analytical solution for
nucleated polymerization (eqn (1)†). (B) Primary (d) and secondary (k) nucleation parameters obtained by the fits. (C, D) Typical ThT kinetics above
the COC (blue circles), and their underlying RF kinetics (orange circles) obtained after subtracting the oligomeric portion of the fit (red line) from
the data for hewL (C) and dimAb (D). (E, F) RF lag times of hewL (E) and dimAb (F) extracted from fits to experimental kinetics below (orange) and
above (blue) the COC. The solid lines are power-law fits through these specific data sets below the COC (exponent a¼(0.17 0.02) (hewL) and
(0.32 0.06) (dimAb)). Three or four, respectively, independent repeats of thesemeasurements yielded power law values of a¼(0.24 0.07)
(hewL) and a ¼ (0.32  0.05) (dimAb).
This journal is © The Royal Society of Chemistry 2018 Chem. Sci., 2018, 9, 5937–5948 | 5943
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conditions above the COC. They are non-obligatory since RFs
can readily form above and below the COC. To gain a better
understanding of the transition from sigmoidal to biphasic
growth kinetics not just during the initial stage of RF nucleation
but over the entire range of reaction time scales, we adopted the
off-pathway kinetics model originally proposed by Powers and
Powers,75 but modied it in two signicant ways. First, off-
pathway oligomer formation was limited to concentrations
above the COC. In addition, we needed to include secondary
nucleation mechanisms for on-pathway bril growth in order to
replicate the experimentally observed RF kinetics. Details of the
numerical scheme are provided in the ESI.† An example of
tting experimental kinetics below and above the COC to
simulated growth kinetics is illustrated in Fig. 6 (for further
examples see Fig. S4†). This off-pathway kinetic model readily
replicates the transition from sigmoidal to biphasic behavior
seen in our experimental data. Equally important, it provides
a natural decomposition of the ThT signal into its gO/CF and RF
components. Since the current model does not include mech-
anisms to account for active inhibition of RFs by gO/CF
formation, the parameters for RF formation rates had to be
adjusted to match the individual kinetic curves.
Discussion
The combined kinetics and imaging data reported here show
that the sharp transition in amyloid assembly from sigmoidal to
biphasic kinetics coincides with the onset of gO/CF formation
above a protein and solution-condition dependent COC (Fig. 2A
and C). Prior reports of biphasic ThT kinetics for Ab43,63,66 and
Sup35 yeast protein42 suggest that biphasic kinetics represent
a generic mode for amyloid assembly. Similarly, there are
previous reports associating a micelle-like transition in
Ab40,64,76,77 amylin,78 b-microglobulin,21 and lysozyme,46 with
the formation of gO/CFs. Our data indicate that biphasic
kinetics represents a generic mode of amyloid assembly that is
directly related to the formation of metastable gO/CF formation,
and is distinct from the sigmoidal kinetics associated with
nucleated polymerization of RFs from monomers. The lack of
any detectable gO/CFs below the COC (Fig. 2D) and their
inability to accelerate RF nucleation and growth under those
conditions (Fig. 3A) indicates that metastable gO/CFs are not
precursors of RFs. This distinguishes gO/CFs from any on-
pathway oligomeric bril seeds transiently formed below the
COC.
We presume that the commonly observed formation of gO/
CFs and RFs by various amyloid proteins, and over a wide
range of solution conditions, arises from two basic yet distinct
features of polypeptide chains: their amphiphilic nature and
their propensity to form intermolecular hydrogen bonds across
their backbone. The latter is well established as the funda-
mental driving force underlying RF formation.79 Similarly, the
amphiphilic character of polypeptide chains has been repeat-
edly suggested to contribute to the existence of a COC and gO
formation.77,78 We have previously provided a quantitative
colloidal model replicating both the salt and protein concen-
tration dependence of the COC of hewL.46 The available struc-
tural data suggest that gOs are short anti-parallel b-barrels,80
clearly distinct from the steric zipper structure of RFs. GO/CFs
arising from amphiphilic phase separation vs. RFs via inter-
molecular hydrogen bonding also rationalizes the existence of
two distinct aggregate species formed along separate assembly
pathways. Furthermore, it explains why they have distinct
morphologies and mechanical rigidities (sterically constrained
gOs polymerizing into weakly-linked CFs vs. mechanically rigid
hydrogen-linked RFs), their relative thermodynamic stabilities
(weaker linked gO/CFs vs. strongly bonded RFs), the distinct
reaction orders of their formation (as reported here), their
dependence on various solution parameters such as pH, ionic
strength, specic ion effects, and of course, their dependence
on the primary sequence of the polypeptide chain itself.
Recently, it has been proposed that the switch from RFs to
gO/CFs in b-lactoglobulin at strongly hydrolyzing conditions
(90 C, pH 2) results from concentration-dependent changes to
the distributions of hydrolyzed fragments.81 It is possible that
different peptides do undergo either gO/CF or RF formation at
identical solution conditions. For our hewL assembly condi-
tions (52 C, pH 2) we have shown that the switch from RF to gO/
CF formation can be readily induced by increasing salt at xed
protein concentrations (see horizontal lines in Fig. 1B),46 while
hydrolysis rates across the COC were unchanged (Fig. 4 in ref.
54). Here we show that pre-hydrolyzing hewL for multiple days
has no discernible effect on RF kinetics which, due to its long
lag periods, would be most susceptible to hydrolysis (see
Fig. S5†). Hence, we believe hydrolysis is not fundamental to the
switch from RF to gO/CF formation.
The sharp transition from “oligomer-free” to “oligomeric”
RF growth upon crossing the COC allowed us to address a long-
standing question: what role do metastable gO/CFs play in the
nucleation–polymerization of RFs? Qualitatively, NCC ts well
with the lag-free emergence of gO/CFs and the biphasic kinetics
for gO/CF growth with late-stage RF nucleation and growth.
However, the inability of gO/CFs to seed RF growth below the
COC (Fig. 3A) and their inhibitory effects on RF formation above
the COC (Fig. 5E and F) are inconsistent with NCC. We note,
however, that protein-specic factors such as the structure of
the protein undergoing assembly or the size and structure of its
Fig. 6 Numerical simulation of biphasic ThT kinetics. Fit of the
experimental ThT kinetics for 280 mM hewL (black) to the dual-
pathway assembly model (green) and corresponding decomposition
into its RF (orange) and gO/CF (blue) components.
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oligomers might affect whether NCC is a feasible RF nucleation
mechanism under other conditions. Large liquid-like droplets
have been reported to arise during polyQ bril assembly or b2
microglobulin disassembly.82,83 Hence, there remains uncer-
tainty whether there are multiple, potentially distinct meta-
stable states, and how those might be related to each other and
to late-stage brils.
Extrapolating NP scaling laws, established below the COC, to
monomer concentrations above the COC allowed us to quantify
how gO/CF formation altered NP. Crossing the COC, the scaling
law for lag periods with monomer concentration initially
developed a kink. Kinks in the scaling behavior of RF lag
periods, albeit to a lesser degree, have been reported for insulin,
bovine serum albumin and lysozyme.39,41,84 Even inverse rela-
tionships between half-time and/or lag-time of amyloid bril
growth have been observed before for the light chain variable
domain LEN,85 ribosomal protein S6,86 glucagon-like peptide-
1,31 and Ab66 and have been explained with competing off-
pathway aggregation. A model for competing off-pathway
aggregation by Powers and Powers75 did generate an inverse
relationship between half-time for reaction completion (but not
lag-time) of amyloid formation at high protein concentration,
due to monomer depletion by off-pathway precipitates. Impor-
tantly, though, COC-limited monomer depletion can only
explain an arrest but not the increase in the RF lag-times re-
ported here. The identied active inhibition of RF formation by
gO/CFs necessitates modication of the standard cNP model
(Fig. 7).
The COCs observed here are relatively high compared to
typical in vivo protein concentrations. For example, dimAb,
although showing increased oligomerization propensity due to
covalent linkage of two Ab units, has a COC of the order of 1 mM
(in low salt buffer at neutral pH), whereas physiological Ab
concentrations are in the nanomolar range.87 Similar discrep-
ancies, though, exist for Ab bril solubilities, with the latter
ranging from hundreds of nanomolar to millimolars. It is
important to realize in this context that there are multiple
factors that can signicantly reduce COCs or increase local
protein concentrations in vivo. These include salt concentration
and pH (see Fig. 1B) (e.g., accumulation of micromolar
concentrations of Ab in acidic vesicles87); interfaces, such as
membrane or bril surfaces;88 post-translational modications
such as cross-links;30 macromolecular crowding;89 and disease-
related mutations, some of which strongly promote gO/CF
formation.17,90,91 Moreover, interactions with other cellular
components may affect gO/CF formation. For example, inter-
action with another aggregation-prone protein, TDP-43, was
shown to strongly promote gO/CF formation of Ab at the
expense of RF formation.92 The relatively high COCs observed
for the two model systems therefore likely result from the
present experimental conditions. Interestingly, reduced
expression of APP in mouse models that did not affect plaque
load led to reduced formation of plaque-unrelated oligomers,
suggesting that the concentration dependence of gO/CF
formation has a correlate in vivo.93,94
The above results paint a complex picture of how RF
formation proceeds in the presence of gO/CFs. The mutual
interactions among gO/CFs and RFs, either direct or via the
monomer pool, are likely to feature prominently in the temporal
evolution of gO/CFs vs. RF populations in vivo, as well. There are
solid indications that gO/CFs and RFs have distinct biological/
pathological activity proles that might vary with protein
identity, its growth conditions, and its cellular environ-
ment.20,27,57,95–98 The retarding effects of early-stage gOs on the
nucleation and growth of late-stage RFs might result in
extended exposure to toxic oligomers and low rates of RF
formation and gO/CF depletion in vivo. This provides one
possible explanation for the paradoxical observations that post-
mortem RF loads correlate poorly with the severity of clinical
symptoms.99,100 Overall, systematic investigation of the ther-
modynamic and kinetic factors regulating the assembly of
distinct amyloid species in vitro and their mutual interplay can
provide important insights into the mechanisms regulating
amyloid assembly in vivo.
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